(TRAK) ReposiTrak - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7002153044

TRAK: Software, Supply Chain, Compliance, Traceability, E-commerce, Consulting

ReposiTrak, Inc. (NASDAQ:TRAK), a SaaS provider, offers a suite of proprietary software solutions tailored for the retail and supply chain sectors in North America. Their platform includes ReposiTrak MarketPlace, which facilitates supplier discovery and B2B e-commerce through streamlined digital interactions. The Compliance and Food Safety solutions mitigate regulatory risks by automating compliance tracking and monitoring, ensuring adherence to food safety standards. Additionally, their Supply Chain solutions enhance supplier relationship management through improved communication and process optimization. The Traceability Network captures critical product data, enabling precise tracking and recall management. The company also provides consulting services to retailers and suppliers across grocery, convenience, and specialty sectors, focusing on operational efficiency and compliance. Headquartered in Murray, Utah, ReposiTrak, formerly Park City Group, rebranded in December 2023. They have partnered with Upshop to enhance grocery retail traceability.

From a technical standpoint, TRAKs average 20-day volume is 45,556, with a last price of $18.98. The SMA20 at $20.76 and SMA50 at $21.52 suggest a bearish trend below these moving averages. The ATR of 0.81 indicates low volatility, signaling stable price movements. Fundamentally, with a market cap of $391.20M, TRAKs high P/E of 73.93 and P/B of 8.04 may indicate overvaluation, despite a positive RoE of 13.24. The P/S ratio of 17.79 reflects strong revenue per share.

3-Month Forecast: TRAK is expected to trade sideways to slightly down, influenced by its position below key SMAs. Support may be found near $18.50, with resistance at $21.00. The low ATR suggests minimal price fluctuations, likely ranging between $18.00 and $20.00. While the companys strong market position and partnerships are positives, high valuations may lead to a correction, making the stock sensitive to broader market movements.

Additional Sources for TRAK Stock

TRAK Stock Overview

Market Cap in USD 391m
Sector Technology
Industry Software - Application
GiC Sub-Industry Application Software
IPO / Inception 1998-11-19

TRAK Stock Ratings

Growth Rating 84.6
Fundamental 66.1
Dividend Rating 43.5
Rel. Strength 20
Analysts 4/5
Fair Price Momentum 22.56 USD
Fair Price DCF 12.38 USD

TRAK Dividends

Dividend Yield 12m 0.17%
Yield on Cost 5y 0.91%
Annual Growth 5y 49.38%
Payout Consistency 66.4%

TRAK Growth Ratios

Growth Correlation 3m -72.8%
Growth Correlation 12m 79.2%
Growth Correlation 5y 84.4%
CAGR 5y 40.32%
CAGR/Max DD 5y 0.78
Sharpe Ratio 12m -0.28
Alpha 13.48
Beta 0.785
Volatility 62.61%
Current Volume 73.5k
Average Volume 20d 62.1k
What is the price of TRAK stocks?
As of April 11, 2025, the stock is trading at USD 19.84 with a total of 73,526 shares traded.
Over the past week, the price has changed by +6.32%, over one month by +1.33%, over three months by -4.25% and over the past year by +14.72%.
Is ReposiTrak a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, ReposiTrak (NASDAQ:TRAK) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.05 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRAK as of April 2025 is 22.56. This means that TRAK is currently undervalued and has a potential upside of +13.71% (Margin of Safety).
Is TRAK a buy, sell or hold?
ReposiTrak has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy TRAK.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for TRAK stock price target?
According to ValueRays Forecast Model, TRAK ReposiTrak will be worth about 24.9 in April 2026. The stock is currently trading at 19.84. This means that the stock has a potential upside of +25.55%.
Issuer Forecast Upside
Wallstreet Target Price 24 21%
Analysts Target Price 24 21%
ValueRay Target Price 24.9 25.6%